343 related articles for article (PubMed ID: 28522325)
21. Efficient and allele-specific genome editing of disease loci in human iPSCs.
Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
[TBL] [Abstract][Full Text] [Related]
22. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system.
Torres R; Martin MC; Garcia A; Cigudosa JC; Ramirez JC; Rodriguez-Perales S
Nat Commun; 2014 Jun; 5():3964. PubMed ID: 24888982
[TBL] [Abstract][Full Text] [Related]
23. Desmoplastic small round cell tumor-clinicopathological spectrum, including unusual features and immunohistochemical analysis of 45 tumors diagnosed at a tertiary cancer referral centre, with molecular results t(11; 22) (p13; q12) (EWS-WT1) in select cases.
Rekhi B; Ahmed S; Basak R; Qureshi SS; Desai SS; Ramadwar M; Desai SB; Kurkure P; Jambhekar NA
Pathol Oncol Res; 2012 Oct; 18(4):917-27. PubMed ID: 22434317
[No Abstract] [Full Text] [Related]
24. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
25. Germline Cas9 expression yields highly efficient genome engineering in a major worldwide disease vector,
Li M; Bui M; Yang T; Bowman CS; White BJ; Akbari OS
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10540-E10549. PubMed ID: 29138316
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor.
Slotkin EK; Bowman AS; Levine MF; Dela Cruz F; Coutinho DF; Sanchez GI; Rosales N; Modak S; Tap WD; Gounder MM; Thornton KA; Bouvier N; You D; Gundem G; Gerstle JT; Heaton TE; LaQuaglia MP; Wexler LH; Meyers PA; Kung AL; Papaemmanuil E; Zehir A; Ladanyi M; Shukla N
Mol Cancer Res; 2021 Jul; 19(7):1146-1155. PubMed ID: 33753552
[TBL] [Abstract][Full Text] [Related]
27. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
Shou J; Li J; Liu Y; Wu Q
Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
[TBL] [Abstract][Full Text] [Related]
28. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
29. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila.
Gratz SJ; Ukken FP; Rubinstein CD; Thiede G; Donohue LK; Cummings AM; O'Connor-Giles KM
Genetics; 2014 Apr; 196(4):961-71. PubMed ID: 24478335
[TBL] [Abstract][Full Text] [Related]
30. Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing.
Yin J; Lu R; Xin C; Wang Y; Ling X; Li D; Zhang W; Liu M; Xie W; Kong L; Si W; Wei P; Xiao B; Lee HY; Liu T; Hu J
Nat Commun; 2022 Mar; 13(1):1204. PubMed ID: 35260581
[TBL] [Abstract][Full Text] [Related]
31. Creating Heritable Mutations in Drosophila with CRISPR-Cas9.
Port F; Bullock SL
Methods Mol Biol; 2016; 1478():145-160. PubMed ID: 27730579
[TBL] [Abstract][Full Text] [Related]
32. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
[TBL] [Abstract][Full Text] [Related]
33. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-mediated genome editing in plants.
Liu X; Xie C; Si H; Yang J
Methods; 2017 May; 121-122():94-102. PubMed ID: 28315486
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
[TBL] [Abstract][Full Text] [Related]
36. The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.
Jasin M; Haber JE
DNA Repair (Amst); 2016 Aug; 44():6-16. PubMed ID: 27261202
[TBL] [Abstract][Full Text] [Related]
37. Improving CRISPR-Cas9 On-Target Specificity.
Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Rehman K
Curr Issues Mol Biol; 2018; 26():65-80. PubMed ID: 28879857
[TBL] [Abstract][Full Text] [Related]
38. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
[TBL] [Abstract][Full Text] [Related]
39. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
[TBL] [Abstract][Full Text] [Related]
40. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
